콘텐츠로 건너뛰기
주식/증권 📈 긍정적

ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?

요약

Illumina shares surge 98.7% in a year as NovaSeq X adoption accelerates, clinical sequencing demand grows, and the company tops Q1 2026 guidance.